Development of a model system for preliminary evaluation of tissue-engineered vascular conduits

Keyphrases

• Tissue-engineered Constructs 100%
• Severe Combined Immunodeficiency 100%
• Vascular Conduit 100%
• Patency 100%
• Microcomputed Tomography 66%
• Tissue Scaffolds 66%
• Human Cells 66%
• Tissue Engineered Vascular Graft 66%
• Clinical Examination 66%
• Ultrasound Interrogation 66%
• Interposition Graft 66%
• Postoperative Day 66%
• Neovessel 33%
• Mouse Model 33%
• Tissue Engineering 33%
• Xenograft 33%
• Engineering Technique 33%
• Euthanized 33%
• Female Mice 33%
• Long-term Efficacy 33%
• Vascular Graft 33%
• Pediatric 33%
• Ingrowth 33%
• Graft Placement 33%
• Long-term Safety 33%
• Long-term Function 33%
• Inferior Vena Cava 33%
• Small Animal Model 33%
• Ovine 33%
• Arteriovenous Graft 33%
• Arterial Grafts 33%
• Decellularized 33%
• Eosin Staining 33%
• Functional Safety 33%
• Hematoxylin Staining 33%
• Non-autologous 33%
• Histologic Evaluation 33%
• High-output Heart Failure 33%
• Graft Insertion 33%
• Venous Graft 33%
• Xenogeneic 33%

Medicine and Dentistry

• Engineered Tissue 100%
• Tissue Regeneration 100%
• Blood Vessel Graft 75%
• Severe Combined Immunodeficiency 75%
• X-Ray Microtomography 50%
• Clinical Examination 50%
• Health Care Cost 25%
• Pediatrics 25%
• Xenograft 25%
• Inferior Vena Cava 25%
• High Output Cardiac Failure 25%
• Haematoxylin 25%
• Arteriole 25%
• Eosin 25%
• Grafting 25%
• Vein Graft 25%
• Artery Graft 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Severe Combined Immunodeficiency 100%
• Mouse Model 33%
• Haematoxylin 33%
• High Output Heart Failure 33%
• Eosin 33%